Question: Which Yojana of Central Government provides Rs. 500 monthly to all TB notified TB patients?
(a) TB Aarogya Yojana
(b) TB Poshan Yojana
(c) TB Niroga Yojana
(d) Nikshay Poshan Yojana
- The Minister of State Shri Ashwini Kumar Choubey in his written reply in the Rajya Sabha 5th Feb 2019 informed that the government has launched Nikshay Poshan Yojana in the 2018 with an aim to tackle Tuberculosis by 2025; the scheme provides Rs 500 monthly to all TB notified patients for nutritional and medicinal support.
- As per World Health Organization (WHO) statistics for India 2016, India has around 2.79 million TB cases.
Measures taken by Government:
- Early diagnosis of all the TB patients, prompt treatment with quality assured daily treatment regimen along with suitable patient support systems to promote adherence to prevent the development of drug resistance among any patient. To identify the drug resistance at early stage, all TB patient are being screened for detection of resistance under Universal Drug Susceptible Testing (U-DST). Revised guidelines for Programmatic Management of Drug Resistant TB (PMDT) are being implemented since December 2017.
- Increase in diagnostic and management capacity for early detection and consequent earlier initiation of treatment. This will aid in decreasing mortality and cutting down transmission of the infection.
- The country has 1180 functional CB-NAAT sites, 89 Culture and Drug Susceptibility Testing (C-DST) laboratories certified in various technologies for drug resistance-TB detection.
- Various interventions like Integrated mechanism for management of Adverse Drug Reactions (ADRs), provision of patients & family counselling at the time of diagnosis and during the course of treatment, airborne infection control as well as grievance redressal mechanism have been introduced to improve patient compliance.
- Private sector engagement is being promoted to reach out to all patients who are seeking treatment in the private sector and efforts are being made to provide them all diagnostic, treatment and care facilities, including public health action such as counselling, nutritional support, contact tracing etc.
- Newer evidence-based regimens have been introduced to improve the treatment outcomes of drug resistance TB patients. These are-
- The Shorter MDR Regimen for MDR/RR TB patients (9-11 months of regimen instead of 24 months of conventional regimen)
- Newer drugs (Bedaquiline) containing regimen has also been introduced country-wide under the program and made accessible to all districts during 2018.
- Newer drugs (Delamanid) containing regimen has been introduced in 7 states.